Quantum Biopharma Ltd (QNTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 4,678 | 4,853 | 3,397 | 6,241 | 4,181 |
| Operating Income | -4,678 | -4,853 | -3,397 | -6,241 | -4,181 |
| Interest Expense | 92 | 117 | 22 | 2 | 10 |
| Other Income | 22 | -4,796 | -5,320 | 787 | 176 |
| Pre-tax Income | -4,748 | -9,766 | -8,740 | -5,456 | -4,015 |
| Net Income Continuous | -4,748 | -9,766 | -8,740 | -5,456 | -4,015 |
| Minority Interests | 571 | -513 | N/A | -284 | -188 |
| Net Income | $-5,319 | $-9,253 | $-8,740 | $-5,172 | $-3,827 |
| EPS Basic Total Ops | -1.25 | -3.23 | -3.53 | -5.24 | -4.37 |
| EPS Basic Continuous Ops | -1.25 | -3.23 | -3.53 | -5.24 | -4.37 |
| EPS Diluted Total Ops | -1.25 | -3.23 | -3.53 | -5.24 | -4.37 |
| EPS Diluted Continuous Ops | -1.25 | -3.23 | -3.53 | -5.24 | -4.37 |
| EPS Diluted Before Non-Recurring Items | -1.25 | -3.23 | -1.41 | -2.89 | -4.37 |
| EBITDA(a) | $-4,533 | $-4,712 | $-3,268 | $-6,128 | $-4,060 |